Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3

Review

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

       
Total article views   HTML views PDF downloads Totals
13,404 Dovepress* 11,121+ 4,562 15,683
PubMed Central* 2,283 129 2,412
Totals 13,404 4,691 18,095
*Since 4 August 2011
+Since July 2016

View citations on PubMed Central and Google Scholar